Ensuring Patient Safety in Oncology Drug Development

The development and marketing of oncology drugs comes with unique challenges – such as high toxicity, their potential for long term effects, and their use in vulnerable patient populations. This necessitates the need for rigorous pharmacovigilance measures and implementation of a robust pharmacovigilance system.

Choosing the right pharmacovigilance company to partner with can significantly impact a Marketing Authorisation holder’s success. With the right services and technology, the implementation of a good pharmacovigilance system can help manufacturers to reduce the risk of adverse drug reactions, to comply with regulations, and to develop safer drugs for patients.

 

Download here